D.E. Shaw & Co’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-21,300
Closed -$2.55M 5999
2021
Q4
$2.55M Hold
21,300
﹤0.01% 3123
2021
Q3
$2.63M Sell
21,300
-12,600
-37% -$1.62M ﹤0.01% 2763
2021
Q2
$4.07M Buy
33,900
+21,300
+169% +$2.43M ﹤0.01% 2229
2021
Q1
$1.32M Buy
+12,600
New +$1.28M ﹤0.01% 2895
2018
Q2
Sell
-3,000
Closed -$231K 3924
2018
Q1
$231K Buy
+3,000
New +$222K ﹤0.01% 3268
2014
Q3
Sell
-38,700
Closed -$1.51M 4419
2014
Q2
$1.51M Hold
38,700
﹤0.01% 2560
2014
Q1
$1.41M Buy
+38,700
New +$1.41M ﹤0.01% 2727

Other funds holding XYL

D.E. Shaw & Co's XYL Position: Q1 2026 in Review

D.E. Shaw & Co increased its Xylem (XYL) stake by 70% in Q1 2026, buying an estimated $34.7M and bringing the position to 642,062 shares worth $76.7M. The position accounts for 0.05% of the portfolio, ranked #484.

D.E. Shaw & Co first reported a position in XYL in Q2 2013 and has held it in 45 quarters since. The position peaked at $96M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • D.E. Shaw & Co held 642,062 shares of Xylem worth $76.7M as of Q1 2026.
  • D.E. Shaw & Co bought 264,816 Xylem shares in Q1 2026, an estimated $34.7M.
  • Xylem made up 0.05% of D.E. Shaw & Co's portfolio in Q1 2026, its #484 holding.
  • D.E. Shaw & Co first reported a position in Xylem in Q2 2013 and has held it in 45 quarters since.
  • D.E. Shaw & Co's Xylem position peaked at $96M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.